⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago
🛡️ EUSW
🇬🇧
💊 Medicine AT August 17, 2026

Medikinet retard 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung 20 mg (Hartkapsel mit veränderter Wirkstofffreisetzung)

📷 Wikipedia: Methylphenidate · Source
Medikinet retard 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung 20 mg (Hartkapsel mit veränderter Wirkstofffreisetzung)
📷 Wikipedia: Methylphenidate · Source
Medikinet retard 20 mg modified-release hard capsules Parallel export ban in effect. Affected packs: 30-count box, blister pack (unavailable since 17 August 2026, restock 30 September 2026); 20-count box, blister pack (available).
⚠️
Shortage ongoing
METHYLPHENIDAT HYDROCHLORID is currently in short supply in AT.
📈 Timeline
25 days active so far
August 18, 2026 September 11, 2026

What is this? This is a capsule medicine called Medikinet retard. It contains methylphenidate to help with focus and attention.

What's happening? The 20 mg strength is not available right now. The 30-count box is out of stock since August 17, 2026. It should return September 30, 2026.

Does this affect me? If you take the 20 mg strength, you may be affected. The 30-count box is also affected.

What should I do? Talk to your pharmacist or doctor about other options while this medicine is unavailable.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: N06BA04 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: MEDICE Arzneimittel Pütter GmbH & Co. KG, Kuhloweg 37, 58638 Iserlohn, Federal Republic of Germany · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-08-17, resupply 2026-09-30] · 20 Stück Schachtel, Blisterpackung [verfügbar]

First published
August 17, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Medikinet retard 20 mg Hartkapseln mit veränderter Wirkstofffreisetzung 20 mg (Hartkapsel mit veränderter Wirkstofffreisetzung). Medikinet retard 20 mg modified-release hard capsules Parallel export ban in effect. Affected packs: 30-count box, blister pack (unavailable since 17 August 2026, restock 30 September 2026); 20-count box, blister pack (available).
When was this alert issued?
This alert was issued on August 17, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.